From: A quantitative multimodal metabolomic assay for colorectal cancer
 | Subgroup | Control | Adenoma | Stage I | Stage II | Stage III | Stage IVa |
---|---|---|---|---|---|---|---|
N | Â | 31Â +Â 9Â +Â 41 | 31 | 8 | 8 | 8 | 38 |
Age, mean (SD) | Â | 60.5 (6.7) | 59.5 (5.9) | 76.9 (6.1) | 67.3 (9.8) | 62.8 (14.8) | 60.5 (9.9) |
Gender | Male | 58 (72) | 21(68) | 5 (63) | 7(88) | 4 (50) | 30 (79) |
Female | 23 (28) | 10 (32) | 3 (37) | 1 (11.2) | 4 (50) | 8 (11) | |
Primary Site | Colon | – | – | 2 | 3 | 5 | – |
Rectum | – | – | 5 | 4 | 3 | – | |
Unknown | – | – | 1 | 1 | 0 | – | |
Differentiation | Poor | – | – | 0 | 1 | 2 | 3 |
Moderate | – | – | 4 | 5 | 4 | 26 | |
Well | – | – | 2 | 0 | 2 | 0 | |
Unspecified | – | – | 2 | 2 | 0 | 7 (+2 mucinous) | |
Staging T | T1 | – | – | 1 | – | 3 | – |
T2 | – | – | 5 | – | 2 | – | |
T3 | – | – | – | 7 | 1 | – | |
T4 | – | – | – | 0 | 0 | – | |
Unspecified | – | – | 2 | 1 | 2 |  | |
Staging N | N1 | – | – | – | – | 4 (N1a = 2) (N1b = 2) | 8 |
N2 | – | – | – | – | 2 (N2a = 1) (N2b = 1) | 8 | |
Unspecified | – | – | – | – | 2 | 22 | |
Tumor dimension (cm) | Largest dimension, mean (SD) | – | – | 2.67 (1.50) | 3.51 (1.99) | 2.7 (2.09) | 2.50 (1.49) |
Min-Max |  |  | 0.5–5 | 2.5–6 | 2.8–5.5 | 0.9–5.1 | |
Pre-sampling Chemotherapy |  | – | – | 1 (13) | 3 (38) | 4 (50) | 17 (45) |